apceth Biopharma joins Lonza as bluebird bio cell therapy contractor
bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.
Archives for December 15, 2016
Lonza to buy Capsugel for $5.5bn, no site divestitures planned
Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings of CHF100m a year by 2019.
Almac to collaborate with Exostar on cloud-based management solutions
Almac Clinical Technologies, part of the Almac Group, has announced a collaboration with Exostar to help mitigate risk associated with intellectual property.
Maryland CRO gets thumbs up in animal testing checkup
Smithers Avanza is granted renewal of full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), with “no recommendation for improvements.”
Cipla to make drugs in Iran in deal with Ahran Tejarat
Cipla Ltd has formed a joint venture with Ahran Tejarat Company to manufacture and sell drugs in Iran.
QuintilesIMS Institute: global drug market to reach $1.5tn in 2021
Total spending on medicines is expected to reach $1.5 trillion by 2021, up 33% from 2016 – with historical amounts of new medicines emerging from the pipeline, according to a recent report by QuintilesIMS Institute.
Evotec completes Cyprotex acquisition
Evotec AG has completed its previously announced acquisition of the preclinical contract research organization (CRO), Cyrotex.